EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution

EQS Total Voting Rights Announcement: Marinomed Biotech AG / Total Voting
Rights Announcement
Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG
with the objective of Europe-wide distribution

31.12.2024 / 10:00 CET/CEST
Total Voting Rights Announcement according to Article 135, Section 1 of
the BörseG transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

══════════════════════════════════════════════════════════════════════════

Marinomed Biotech AG herewith announces pursuant to Sec. 135 Para. 1 of
the Stock Exchange Act, that due to the resolution on the capital increase
of December 05, 2024, the total number of voting rights as at the end of
December 2024 has increased to 1,778,333 voting rights, and the Company’s
new share capital amounts to EUR 1,778,333. The change in the total number
voting rights took effect upon entry in the commercial register on
December 19, 2024.

══════════════════════════════════════════════════════════════════════════

31.12.2024 CET/CEST

══════════════════════════════════════════════════════════════════════════

Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Internet: www.marinomed.com

 
End of News EQS News Service

2055907  31.12.2024 CET/CEST